Recruiting
Genital herpes simplex
RecruitingInvestigational
Study of IM-250 capsules compared to placebo in patients with recurrent genital herpes
Investigational
- Disease:Genital herpes simplex
- Substances:(S)-2-(2',5'-DIFLUORO-[1,1'-BIPHENYL]-4-YL)-N-METHYL-N-(4-METHYL-5-(S-METHYLSULFONIMIDOYL)THIAZOL-2-YL)ACETAMIDE
Countries:
Bulgaria
Bulgaria- Participants:18–64 years
- Substances:(S)-2-(2',5'-DIFLUORO-[1,1'-BIPHENYL]-4-YL)-N-METHYL-N-(4-METHYL-5-(S-METHYLSULFONIMIDOYL)THIAZOL-2-YL)ACETAMIDE
- Sponsor:Innovative Molecules GmbH

